tradingkey.logo

REFILE-Bird flu virus shows mutations in first severe human case in US, CDC says

ReutersDec 26, 2024 11:34 PM

Refiles to add dropped words in government body name in paragraph 1

- The U.S. Centers for Disease Control and Prevention said on Thursday its analysis of samples from the first severe case of bird flu in the country last week showed mutations not seen in samples from an infected backyard flock on the patient's property.

The CDC said the patient's sample showed mutations in the hemagglutinin (HA) gene, the part of the virus that plays a key role in it attaching to host cells.

The health body said the risk to the general public from the outbreak has not changed and remains low.

Last week, the United States reported its first severe case of the virus, in a Louisiana resident above the age of 65, who was suffering from severe respiratory illness.

The patient was infected with the D1.1 genotype of the virus that was recently detected in wild birds and poultry in the United States, and not the B3.13 genotype detected in dairy cows, human cases and some poultry in multiple states.

The mutations seen in the patient are rare but have been reported in some cases in other countries and most often during severe infections. One of the mutations was also seen in another severe case from British Columbia, Canada.

No transmission from the patient in Louisiana to other persons has been identified, said the CDC.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini Ganguli)

((Puyaan.Singh@thomsonreuters.com;))

Disclaimer: For information purposes only. Past performance is not indicative of future results.
tradingkey.logo
tradingkey.logo
Intraday Data provided by Refinitiv and subject to terms of use. Historical and current end-of-day data provided by Refinitiv. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.